ABSTRACT
Introduction Meta-analytic evidence confirms a range of interventions, including mindfulness, physical activity and sleep hygiene, can reduce psychological distress in university students. However, it is unclear which intervention is most effective. Artificial intelligence (AI) driven adaptive trials may be an efficient method to determine what works best and for whom. The primary purpose of the study is to rank the effectiveness of mindfulness, physical activity, sleep hygiene and an active control on reducing distress, using a multi-arm contextual bandit-based AI-adaptive trial method. Furthermore, the study will explore which interventions have the largest effect for students with different levels of baseline distress severity.
Methods and analysis The Vibe Up study is a pragmatically-oriented, decentralised AI-adaptive group sequential randomised controlled trial (RCT) comparing the effectiveness of one of three brief, two week digital self-guided interventions (mindfulness, physical activity, or sleep hygiene) or active control (ecological momentary assessment) in reducing self-reported psychological distress in Australian university students. The adaptive trial methodology involves up to 12 sequential mini-trials that allow for the optimisation of allocation ratios. The primary outcome is change in psychological distress (DASS-21 total score) from pre-intervention to post-intervention. Secondary outcomes include change in depression, anxiety, and stress (measured by DASS-21 subscales) from pre-intervention to post-intervention. Planned contrasts will compare the four groups (i.e., the three intervention and control) using self-reported psychological distress at pre-specified time points for interim analyses. The study aims to determine the best performing intervention, as well as ranking of other interventions.
Ethics and dissemination Ethical approval was sought and obtained from the UNSW Sydney Human Research Ethics Committee (HREC A, HC200466). A trial protocol adhering to the requirements of the Guideline for Good Clinical Practice [1] was prepared for and approved by the Sponsor, UNSW Sydney (Protocol number: HC200466_CTP).
Registration details The trial is registered with the Australian New Zealand Clinical Trials Registry (AC-TRN12621001223820).
Strengths
The study addresses an important clinical question using novel, advanced methods
The trial uses short-duration interventions designed to improve coping responses to transient stressors, which addresses the most common needs of university students
A value of information analysis is included to compare the value of the new trial methods with traditionalapproaches
Digital phenotyping is used to explore smartphone sensor information with clinical outcomes
Weaknesses
More than 12 mini-trials might be required to determine the ranking for the interventions
The interventions may prove to be of the same level of effectiveness for each level of severity
Interventions other than those examined in this study, such as CBT, may be more effective and remain untested
The methodology assumes that the three digital interventions are configured to deliver similar doses and/or have approximate fidelity with standard methods
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
AC-TRN12621001223820
Funding Statement
This work was supported by Commonwealth of Australia Medical Research Future Fund grant MRFAI000028 Optimising treatments in mental health using AI
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was sought and obtained from the UNSW Sydney Human Research Ethics Committee (HREC A, HC200466). A trial protocol adhering to the requirements of the Guideline for Good Clinical Practice [1] was prepared for and approved by the Sponsor, UNSW Sydney (Protocol number: HC200466_CTP).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Distribution/Ruse option was changed.
Data Availability
Access to participant-level data will be subject to the governance procedures of a planned data repository, accessible to researchers and non-commercial users, that will contain the data arising from this study
